Can ParC Ser83Ile status predict fluoroquinolone efficacy in Mycoplasma genitalium infection?

The Lancet Infectious Diseases(2022)

引用 1|浏览1
暂无评分
摘要
In their Personal View, Emma Sweeney and colleagues suggested that detecting wild-type ParC Ser83 sequence and the Ser83Ile mutation could instruct the clinical use of fluoroquinolone in Mycoplasma genitalium infection.1 However, some issues in the Personal View require further discussion.
更多
查看译文
关键词
mycoplasma genitalium infection,mycoplasma genitalium,fluoroquinolone efficacy,parc ser83ile status
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要